Mariner
AMED

Mariner’s Amedisys AMED Stock Holding History

Mariner’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,382
Closed -$333K – 3557
2025
Q2 		$333K Buy
3,382
+312
+10% +$29.5K ﹤0.01% 2640
2025
Q1 		$284K Buy
+3,070
New +$283K ﹤0.01% 2676

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's AMED Position: Q3 2025 in Review

Mariner sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,382 shares — an estimated $333K sold.

Mariner first reported a position in AMED in Q1 2025 and held it in 2 quarters. The position peaked at $333K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mariner reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 3,382 Amedisys shares in Q3 2025, an estimated $333K.
  • Mariner first reported a position in Amedisys in Q1 2025 and held it in 2 quarters.
  • Mariner's Amedisys position peaked at $333K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.